Five industry and research associations involved in institutional public private partnerships (IPPP), known as Joint Undertakings under Horizon 2020, recommend strongly maintaining the public-private partnerships instrument in the next EU Research and Innovation Framework Programme (FP9).

In a joint declaration published on 25 October, co-signed by EFPIA, the five signatories* highlight the major added value that these partnerships are creating for society, jobs, European market growth and competitiveness. 

For more information about the results and impact delivered by the Innovative Medicines Initiative (IMI) since its creation in 2008, read Carrying the torch - IMI outputs and results.

Read the joint declaration

* The five signatories are:

- AeroSpace and Defence Industries Association of Europe (ASD),

- Bio-based Industries Consortium (BIC)

- European Federation of Pharmaceutical Industries and Associations (EFPIA)

- Hydrogen Europe,

- Association of the European Rail Industry (UNIFE)